EUR 13.55
(-1.24%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 525 Million | 361 Million | 326 Million | 389 Million | 369 Million | 462 Million |
Net Income | 493 Million | 323 Million | 160 Million | 310 Million | 266 Million | 590 Million |
Depreciation & Amortization | 543 Million | 618 Million | 408 Million | 317 Million | 389 Million | 253 Million |
Deferred income taxes | -463 Million | - | -280 Million | -282 Million | -181 Million | -446 Million |
Stock-based compensation | 40 Million | 35 Million | 28 Million | 29 Million | 25 Million | 37 Million |
Change in working capital | -96 Million | -66 Million | -12 Million | 8 Million | -118 Million | 10 Million |
Other non-cash items | 8 Million | -549 Million | 22 Million | 7 Million | -12 Million | 18 Million |
Investing Cash Flow | -301 Million | 13 Million | -80 Million | 591 Million | -325 Million | 211 Million |
Investments in PPE | -126 Million | -147 Million | -176 Million | -134 Million | -193 Million | -200 Million |
Acquisitions | -214 Million | 100 Million | 18 Million | 625 Million | -186 Million | 96 Million |
Investment purchases | -8 Million | -12 Million | -4 Million | -6 Million | -12 Million | -12 Million |
Sales/Maturities of investments | 7 Million | 17 Million | 48 Million | -64 Million | 7 Million | 16 Million |
Other Investing Activities | 40 Million | 55 Million | 34 Million | 170 Million | 59 Million | 311 Million |
Financing Cash Flow | -450 Million | -804 Million | -414 Million | -299 Million | -102 Million | -729 Million |
Debt repayment | -285 Million | -171 Million | -167 Million | -230 Million | -48 Million | -441 Million |
Dividends payments | -154 Million | -156 Million | -149 Million | -146 Million | -147 Million | -136 Million |
Common Stock Repurchased | -221 Million | -390 Million | -16 Million | -182 Million | -52 Million | -153 Million |
Common Stock Issuance | 9 Million | 7 Million | 6 Million | 6 Million | 7 Million | 6 Million |
Other Financing Activities | 201 Million | -94 Million | -88 Million | 253 Million | 138 Million | -5 Million |
Accounts receivables | -24 Million | 33 Million | -71 Million | -1 Million | 59 Million | -15 Million |
Accounts payables | 24 Million | -33 Million | 71 Million | 1 Million | -59 Million | - |
Inventory | 9 Million | -34 Million | 22 Million | 35 Million | -20 Million | -10 Million |
Other working capital | -81 Million | -32 Million | -34 Million | -27 Million | -98 Million | 20 Million |
Cash at beginning of period | 543 Million | 937 Million | 1.11 Billion | 434 Million | 525 Million | 630 Million |
Cash at end of period | 309 Million | 543 Million | 937 Million | 1.11 Billion | 434 Million | 525 Million |
Capital Expenditure | -126 Million | -147 Million | -176 Million | -134 Million | -193 Million | -200 Million |
Effect of forex changes on cash | -8 Million | 36 Million | -8 Million | -2 Million | -33 Million | -49 Million |
Net cash flow / Change in cash | -234 Million | -394 Million | -176 Million | 679 Million | -91 Million | -105 Million |
Free Cash Flow | 399 Million | 214 Million | 150 Million | 255 Million | 176 Million | 262 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 78.5 Million | 78.5 Million | 493 Million | 96 Million | 96 Million | 93 Million |
Depreciation & Amortization | 30 Million | 30 Million | 543 Million | 36 Million | 36 Million | 31 Million |
Deferred income taxes | - | - | -463 Million | - | - | -872.96 Million |
Stock-based compensation | 11.5 Million | 11.5 Million | 40 Million | 10.5 Million | 10.5 Million | 9.5 Million |
Change in working capital | -22.5 Million | -22.5 Million | -96 Million | -1 Million | -1 Million | -37 Million |
Other non-cash items | -60 Million | -60 Million | 8 Million | 114.5 Million | 114.5 Million | -90 Million |
Investing Cash Flow | -40.5 Million | -40.5 Million | -301 Million | -28.5 Million | -28.5 Million | -122 Million |
Investments in PPE | -9 Million | -9 Million | -126 Million | -7 Million | -7 Million | -8 Million |
Acquisitions | -19 Million | -19 Million | -214 Million | 1 Million | 1 Million | -86.5 Million |
Investment purchases | - | - | -8 Million | - | - | -12.8 Million |
Sales/Maturities of investments | - | - | 7 Million | - | - | 3.49 Million |
Other Investing Activities | -12.5 Million | -12.5 Million | 40 Million | -22.5 Million | -22.5 Million | -27.5 Million |
Financing Cash Flow | 18 Million | 18 Million | -450 Million | -249.5 Million | -249.5 Million | 24.5 Million |
Debt repayment | - | - | -285 Million | - | - | -256.01 Million |
Dividends payments | -53.5 Million | -53.5 Million | -154 Million | -24 Million | -24 Million | -53 Million |
Common Stock Repurchased | -157.5 Million | -157.5 Million | -221 Million | -98 Million | -98 Million | -12.5 Million |
Common Stock Issuance | - | - | 9 Million | - | - | 2.32 Million |
Other Financing Activities | 229 Million | 229 Million | 201 Million | -127.5 Million | -127.5 Million | 90 Million |
Accounts receivables | -17 Million | -17 Million | -24 Million | -2 Million | -2 Million | -10 Million |
Accounts payables | - | - | 24 Million | - | - | -217.61 Million |
Inventory | 500 Thousand | 500 Thousand | 9 Million | 9 Million | 9 Million | -4.5 Million |
Other working capital | -6 Million | -6 Million | -81 Million | -8 Million | -8 Million | -22.5 Million |
Cash at beginning of period | - | - | 543 Million | - | 348 Million | 303.97 Million |
Cash at end of period | 11.5 Million | 11.5 Million | 309 Million | -19.5 Million | -19.5 Million | 348 Million |
Capital Expenditure | -9 Million | -9 Million | -126 Million | -7 Million | -7 Million | -8 Million |
Effect of forex changes on cash | -3.5 Million | -3.5 Million | -8 Million | 2.5 Million | 2.5 Million | -6.5 Million |
Net cash flow / Change in cash | 11.5 Million | 11.5 Million | -234 Million | -19.5 Million | -367.5 Million | 44.02 Million |
Free Cash Flow | 28.5 Million | 28.5 Million | 399 Million | 249 Million | 249 Million | -1.5 Million |
DNLI
PANACEABIO
6301
NAUFF
O
5133